Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of brostallicin (PNU-166196) plus cisplatin in recurrent squamous cell carcinoma of the head and neck
2004-004557-25Phase 2Terminated
- Sponsor
- Nerviano Medical Sciences
- Start
- Aug 2005
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of brostallicin in head and neck squamous cell carcinoma (HNSCC), sponsored by Nerviano Medical Sciences. Started Aug 2005; status: terminated.
02
Drugs
brostallicin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2004-004557-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004557-25.